These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10320349)

  • 1. Inhibition of RNA polymerase II transcription in human cell extracts by cisplatin DNA damage.
    Cullinane C; Mazur SJ; Essigmann JM; Phillips DR; Bohr VA
    Biochemistry; 1999 May; 38(19):6204-12. PubMed ID: 10320349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of transcriptional stalling at cisplatin-damaged DNA.
    Damsma GE; Alt A; Brueckner F; Carell T; Cramer P
    Nat Struct Mol Biol; 2007 Dec; 14(12):1127-33. PubMed ID: 17994106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UV-induced inhibition of transcription involves repression of transcription initiation and phosphorylation of RNA polymerase II.
    Rockx DA; Mason R; van Hoffen A; Barton MC; Citterio E; Bregman DB; van Zeeland AA; Vrieling H; Mullenders LH
    Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10503-8. PubMed ID: 10973477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three transitions in the RNA polymerase II transcription complex during initiation.
    Holstege FC; Fiedler U; Timmers HT
    EMBO J; 1997 Dec; 16(24):7468-80. PubMed ID: 9405375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockage of RNA polymerase II at a cyclobutane pyrimidine dimer and 6-4 photoproduct.
    Mei Kwei JS; Kuraoka I; Horibata K; Ubukata M; Kobatake E; Iwai S; Handa H; Tanaka K
    Biochem Biophys Res Commun; 2004 Aug; 320(4):1133-8. PubMed ID: 15249207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavior of T7 RNA polymerase and mammalian RNA polymerase II at site-specific cisplatin adducts in the template DNA.
    Tornaletti S; Patrick SM; Turchi JJ; Hanawalt PC
    J Biol Chem; 2003 Sep; 278(37):35791-7. PubMed ID: 12829693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin-DNA adducts inhibit ribosomal RNA synthesis by hijacking the transcription factor human upstream binding factor.
    Zhai X; Beckmann H; Jantzen HM; Essigmann JM
    Biochemistry; 1998 Nov; 37(46):16307-15. PubMed ID: 9819223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic and mechanistic analysis of the RNA polymerase II transcrption reaction at the human interleukin-2 promoter.
    Ferguson HA; Kugel JF; Goodrich JA
    J Mol Biol; 2001 Dec; 314(5):993-1006. PubMed ID: 11743717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficiency of extension of mismatched primer termini across from cisplatin and oxaliplatin adducts by human DNA polymerases beta and eta in vitro.
    Bassett E; Vaisman A; Havener JM; Masutani C; Hanaoka F; Chaney SG
    Biochemistry; 2003 Dec; 42(48):14197-206. PubMed ID: 14640687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping the location of TFIIB within the RNA polymerase II transcription preinitiation complex: a model for the structure of the PIC.
    Chen HT; Hahn S
    Cell; 2004 Oct; 119(2):169-80. PubMed ID: 15479635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription-coupled and DNA damage-dependent ubiquitination of RNA polymerase II in vitro.
    Lee KB; Wang D; Lippard SJ; Sharp PA
    Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4239-44. PubMed ID: 11904382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA polymerase II blockage by cisplatin-damaged DNA. Stability and polyubiquitylation of stalled polymerase.
    Jung Y; Lippard SJ
    J Biol Chem; 2006 Jan; 281(3):1361-70. PubMed ID: 16275646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a monofunctional phenanthriplatin-DNA adduct on RNA polymerase II transcriptional fidelity and translesion synthesis.
    Kellinger MW; Park GY; Chong J; Lippard SJ; Wang D
    J Am Chem Soc; 2013 Sep; 135(35):13054-61. PubMed ID: 23927577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulation of the Ig kappa gene by promoter-proximal pausing of RNA polymerase II.
    Raschke EE; Albert T; Eick D
    J Immunol; 1999 Oct; 163(8):4375-82. PubMed ID: 10510378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA polymerase II bypass of oxidative DNA damage is regulated by transcription elongation factors.
    Charlet-Berguerand N; Feuerhahn S; Kong SE; Ziserman H; Conaway JW; Conaway R; Egly JM
    EMBO J; 2006 Nov; 25(23):5481-91. PubMed ID: 17110932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assays for transcription elongation by RNA polymerase II using oligo(dC)-tailed template with single DNA damage.
    Kuraoka I; Tanaka K
    Methods Enzymol; 2006; 408():214-23. PubMed ID: 16793371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CPD damage recognition by transcribing RNA polymerase II.
    Brueckner F; Hennecke U; Carell T; Cramer P
    Science; 2007 Feb; 315(5813):859-62. PubMed ID: 17290000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonistic effects of T-Ag and VP16 reveal a role for RNA pol II elongation on alternative splicing.
    Kadener S; Cramer P; Nogués G; Cazalla D; de la Mata M; Fededa JP; Werbajh SE; Srebrow A; Kornblihtt AR
    EMBO J; 2001 Oct; 20(20):5759-68. PubMed ID: 11598018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of nematode TFIIE function reveal a link between Ser-5 phosphorylation of RNA polymerase II and the transition from transcription initiation to elongation.
    Yamamoto S; Watanabe Y; van der Spek PJ; Watanabe T; Fujimoto H; Hanaoka F; Ohkuma Y
    Mol Cell Biol; 2001 Jan; 21(1):1-15. PubMed ID: 11113176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction, analysis, and transcription of model nucleosomal templates.
    Walter W; Studitsky VM
    Methods; 2004 May; 33(1):18-24. PubMed ID: 15039083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.